Renal function in pediatric liver transplant patients

Area of Science:

• Nephrology
• Pediatric Gastroenterology
• Transplantation Medicine

Background:

• Pediatric orthotopic liver transplantation (OLT) survival rates are now between 75-80% at five years.
• Renal dysfunction is a serious complication following pediatric OLT, categorized into pre-existing disease, hepatorenal syndrome, peri/early post-transplant impairment, and long-term nephrotoxicity.
• Pre-existing conditions like tyrosinemia and congenital cystic kidney disease can be associated with liver disease.

Purpose of the Study:

• To review the categories and influences of renal dysfunction after pediatric OLT.
• To highlight the risks associated with long-term immunosuppressive therapy, specifically cyclosporine and tacrolimus (FK-506).
• To discuss the current understanding and ongoing debates regarding the progression of renal impairment post-transplantation.

Main Methods:

• Review of existing literature on renal dysfunction following pediatric OLT.
• Analysis of studies examining the impact of immunosuppressive agents on renal function (e.g., GFR, hypertension).
• Categorization of renal dysfunction into four main types.

Main Results:

• Long-term use of cyclosporine and tacrolimus (FK-506) is associated with significant decreases in Glomerular Filtration Rate (GFR).
• Studies show a high percentage of pediatric OLT patients experience reduced GFR, with some experiencing hypertension.
• Nephrotoxicity of FK-506 is comparable to cyclosporine, with potential for substantial GFR decline upon conversion.

Conclusions:

• The long-term prognosis for renal function in pediatric OLT patients remains largely unknown.
• Ongoing research is needed to determine if renal impairment is static or progressive.
• Long-term follow-up studies monitoring GFR are essential for managing pediatric OLT recipients.